Kelly A. Volcik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kelly A. Volcik has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Eric Boerwinkle
Human Genetics Center, University of Texas Health Science Center, Houston, TX
7 shared publicationsChristie M. Ballantyne
Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart Center and Baylor College of Medicine, Houston, TX
4 shared publicationsAaron R. Folsom
Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN
3 shared publicationsA. Richey Sharrett
2 shared publicationsJosef Coresh
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, 2024 E. Monument, Baltimore, MD 21205, United States
2 shared publicationsAaron R Folsom
Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN
1 shared publication
Latest Publications
- 1 May 2010
- Published by Wolters Kluwer Health in Stroke
- Vol. 41 (5) , 1038-1040
Intercellular Adhesion Molecule-1 G241R Polymorphism Predicts Risk of Incident Ischemic Stroke
Background and Purpose— Intercellular adhesion molecule-1 levels are increased in pathological studies of atherosclerosis. We evaluated 13 491 participants from the Atherosclerosis Risk in Communities Study to determine the association of intercellular adhesion molecule-1 G241R and K469E polymorphisms with incident coronary heart disease and ischemic stroke. Methods— Incidences of ischemic stroke (N=517) and coronary heart disease (N=1629) through 2003 were determined by annual telephone calls and hospital and death certificate surveillance. Risk factors were measured at the baseline examination. Cox proportional-hazards models were used to estimate hazard rate ratios. Results— The intercellular adhesion molecule-1 G241 RR genotype was associated with a significantly increased risk of ischemic stroke in both whites (hazard rate ratio=2.18; 95% CI, 1.01 to 4.68; P =0.05) and blacks (hazard rate ratio=7.04; 95% CI, 3.72 to 13.3; P Conclusions— The intercellular adhesion molecule-1 241 RR genotype is associated with an increased risk of incident ischemic stroke in both whites and blacks.
- 1 May 2010
- Published by Wolters Kluwer Health in Stroke
- Vol. 41 (5) , 1038-1040
Intercellular Adhesion Molecule-1 G241R Polymorphism Predicts Risk of Incident Ischemic Stroke
Background and Purpose— Intercellular adhesion molecule-1 levels are increased in pathological studies of atherosclerosis. We evaluated 13 491 participants from the Atherosclerosis Risk in Communities Study to determine the association of intercellular adhesion molecule-1 G241R and K469E polymorphisms with incident coronary heart disease and ischemic stroke. Methods— Incidences of ischemic stroke (N=517) and coronary heart disease (N=1629) through 2003 were determined by annual telephone calls and hospital and death certificate surveillance. Risk factors were measured at the baseline examination. Cox proportional-hazards models were used to estimate hazard rate ratios. Results— The intercellular adhesion molecule-1 G241 RR genotype was associated with a significantly increased risk of ischemic stroke in both whites (hazard rate ratio=2.18; 95% CI, 1.01 to 4.68; P =0.05) and blacks (hazard rate ratio=7.04; 95% CI, 3.72 to 13.3; P Conclusions— The intercellular adhesion molecule-1 241 RR genotype is associated with an increased risk of incident ischemic stroke in both whites and blacks.
- 11 January 2010
- Published by Elsevier in Atherosclerosis
- Vol. 210 (1) , 188-193
MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study
- 11 January 2010
- Published by Elsevier in Atherosclerosis
- Vol. 210 (1) , 188-193
MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study
- Open Access
- 1 June 2009
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 55 (6) , 1076-1082
SELP and SELPLG Genetic Variation Is Associated with Cell Surface Measures of SELP and SELPLG: The Atherosclerosis Risk in Communities Carotid MRI Study
Background: P-selectin (SELP) and its ligand, P-selectin glycoprotein ligand 1 (SELPLG), play key roles in both the inflammatory response and the atherosclerotic process. Previous studies have shown genetic variation in the SELP gene [selectin P (granule membrane protein 140kDa, antigen CD62)] to be associated with plasma SELP concentrations; however, the major biological function of SELP (and SELPLG) is at the cell surface. We therefore investigated the association of SELP polymorphisms with platelet SELP measures and polymorphisms in the SELPLG gene (selectin P ligand) with lymphocyte, granulocyte, and monocyte SELPLG measures among 1870 participants in the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.Methods: Whole-blood flow cytometry was used to analyze leukocyte and platelet markers in the ARIC Carotid MRI Study. The allele frequencies for the SELP and SELPLG polymorphisms of whites and African Americans were markedly different; therefore, all analyses were race specific.Results: SELP T715P was significantly associated with lower values for platelet SELP measures in whites (P = 0.0001), whereas SELP N562D was significantly associated with higher values for SELP measures in African Americans (P = 0.02). SELPLG M62I was significantly associated with lower granulocyte and monocyte SELPLG measures in African Americans (P = 0.003 and P = 0.0002, respectively) and with lower lymphocyte SELPLG measures in whites (P = 0.01).Conclusions: Specific SELP and SELPLG polymorphisms were associated with cell surface measures of SELP and SELPLG in both whites and African Americans in the ARIC Carotid MRI Study. To our knowledge, this study is the first to examine the association of SELP and SELPLG genetic variation with measures of cell surface SELP and SELPLG.
- 1 June 2009
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 55 (6) , 1076-1082
Open AccessSELP and SELPLG Genetic Variation Is Associated with Cell Surface Measures of SELP and SELPLG: The Atherosclerosis Risk in Communities Carotid MRI Study
Background: P-selectin (SELP) and its ligand, P-selectin glycoprotein ligand 1 (SELPLG), play key roles in both the inflammatory response and the atherosclerotic process. Previous studies have shown genetic variation in the SELP gene [selectin P (granule membrane protein 140kDa, antigen CD62)] to be associated with plasma SELP concentrations; however, the major biological function of SELP (and SELPLG) is at the cell surface. We therefore investigated the association of SELP polymorphisms with platelet SELP measures and polymorphisms in the SELPLG gene (selectin P ligand) with lymphocyte, granulocyte, and monocyte SELPLG measures among 1870 participants in the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.Methods: Whole-blood flow cytometry was used to analyze leukocyte and platelet markers in the ARIC Carotid MRI Study. The allele frequencies for the SELP and SELPLG polymorphisms of whites and African Americans were markedly different; therefore, all analyses were race specific.Results: SELP T715P was significantly associated with lower values for platelet SELP measures in whites (P = 0.0001), whereas SELP N562D was significantly associated with higher values for SELP measures in African Americans (P = 0.02). SELPLG M62I was significantly associated with lower granulocyte and monocyte SELPLG measures in African Americans (P = 0.003 and P = 0.0002, respectively) and with lower lymphocyte SELPLG measures in whites (P = 0.01).Conclusions: Specific SELP and SELPLG polymorphisms were associated with cell surface measures of SELP and SELPLG in both whites and African Americans in the ARIC Carotid MRI Study. To our knowledge, this study is the first to examine the association of SELP and SELPLG genetic variation with measures of cell surface SELP and SELPLG.
- Open Access
- 1 June 2008
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 87 (6) , 1926-1931
Peroxisome proliferator–activated receptor α genetic variation interacts with n−6 and long-chain n−3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study
Background: Peroxisome proliferator–activated receptor-α (PPARA) regulates the expression of genes involved in lipid metabolism. The binding of polyunsaturated fatty acids (PUFAs) to PPARA results in rapid changes in the expression of genes involved in lipid oxidation, with long-chain n−3 fatty acids being potent activators of PPARA. Objective: We evaluated the potential effect modification of PPARA genetic variation on the association between PUFA intake, specifically n−6 and long-chain n−3 fatty acid intakes, and multiple lipid measures in the large biethnic Atherosclerosis Risk in Communities (ARIC) Study. Design: Study participants (10 134 whites and 3480 African Americans) were selected from the ARIC Study—a prospective investigation of atherosclerosis and its clinical sequelae. Multiple linear regression models were used to assess the relation between PPARA genotypes, as well as dietary fatty acid intake, and baseline lipid measures. PPARA-specific effects of variation were assessed by including genotype-by-fatty acid interaction terms in each statistical model. Results: PPARA genotype frequencies were significantly different between whites and African Americans. No significant associations between lipid measures and PPARA genotype were observed in either whites or African Americans. Significant genotype-by-n−6 fatty acid intake interactions were observed only in whites for the 3′untranslated region (UTR) G→A single nucleotide polymorphism (SNP) and total cholesterol (P = 0.03) and LDL cholesterol (P = 0.03). Significant genotype-by-long-chain n−3 fatty acid intake interactions were observed only in African Americans for the 3′UTR C→T SNP and total cholesterol (P = 0.03) and LDL cholesterol (P = 0.02). Conclusions: Findings from the current study suggest that PPARA 3′UTR SNPs modulate the association between lipid concentrations and dietary n−6 fatty acid intake (in whites) and long-chain n−3 fatty acid intake (in African Americans) such that persons with homozygous variant genotypes have significantly lower total cholesterol and LDL-cholesterol measures when consuming higher quantities of n−6 or long-chain n−3 fatty acids.
- 1 June 2008
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 87 (6) , 1926-1931
Open AccessPeroxisome proliferator–activated receptor α genetic variation interacts with n−6 and long-chain n−3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study
Background: Peroxisome proliferator–activated receptor-α (PPARA) regulates the expression of genes involved in lipid metabolism. The binding of polyunsaturated fatty acids (PUFAs) to PPARA results in rapid changes in the expression of genes involved in lipid oxidation, with long-chain n−3 fatty acids being potent activators of PPARA. Objective: We evaluated the potential effect modification of PPARA genetic variation on the association between PUFA intake, specifically n−6 and long-chain n−3 fatty acid intakes, and multiple lipid measures in the large biethnic Atherosclerosis Risk in Communities (ARIC) Study. Design: Study participants (10 134 whites and 3480 African Americans) were selected from the ARIC Study—a prospective investigation of atherosclerosis and its clinical sequelae. Multiple linear regression models were used to assess the relation between PPARA genotypes, as well as dietary fatty acid intake, and baseline lipid measures. PPARA-specific effects of variation were assessed by including genotype-by-fatty acid interaction terms in each statistical model. Results: PPARA genotype frequencies were significantly different between whites and African Americans. No significant associations between lipid measures and PPARA genotype were observed in either whites or African Americans. Significant genotype-by-n−6 fatty acid intake interactions were observed only in whites for the 3′untranslated region (UTR) G→A single nucleotide polymorphism (SNP) and total cholesterol (P = 0.03) and LDL cholesterol (P = 0.03). Significant genotype-by-long-chain n−3 fatty acid intake interactions were observed only in African Americans for the 3′UTR C→T SNP and total cholesterol (P = 0.03) and LDL cholesterol (P = 0.02). Conclusions: Findings from the current study suggest that PPARA 3′UTR SNPs modulate the association between lipid concentrations and dietary n−6 fatty acid intake (in whites) and long-chain n−3 fatty acid intake (in African Americans) such that persons with homozygous variant genotypes have significantly lower total cholesterol and LDL-cholesterol measures when consuming higher quantities of n−6 or long-chain n−3 fatty acids.
- Open Access
- 2 April 2008
- Published by Springer Nature in BMC Medical Genetics
- Vol. 9 (1) , 23
Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD
Background: The lectin-like oxidized LDL receptor LOX-1 (encoded by OLR1) is believed to play a key role in atherogenesis and some reports suggest an association of OLR1 polymorphisms with myocardial infarction (MI). We tested whether single nucleotide polymorphisms (SNPs) in OLR1 are associated with clinically significant CAD in the Atherosclerotic Disease, VAscular FuNction, & Geneti C Epidemiology (ADVANCE) study. Methods: ADVANCE is a population-based case-control study of subjects receiving care within Kaiser Permanente of Northern California including a subset of participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study. We first resequenced the promoter, exonic, and splice site regions of OLR1 and then genotyped four single nucleotide polymorphisms (SNPs), including a non-synonymous SNP (rs11053646, Lys167Asn) as well as an intronic SNP (rs3736232) previously associated with CAD. Results: In 1,809 cases with clinical CAD and 1,734 controls, the minor allele of the coding SNP was nominally associated with a lower odds ratio (OR) of CAD across all ethnic groups studied (minimally adjusted OR 0.8, P = 0.007; fully adjusted OR 0.8, P = 0.01). The intronic SNP was nominally associated with an increased risk of CAD (minimally adjusted OR 1.12, p = 0.03; fully adjusted OR 1.13, P = 0.03). However, these associations were not replicated in over 13,200 individuals (including 1,470 cases) in the Atherosclerosis Risk in Communities (ARIC) study. Conclusion: Our results do not support the presence of an association between selected common SNPs in OLR1 and the risk of clinical CAD.
- 2 April 2008
- Published by Springer Nature in BMC Medical Genetics
- Vol. 9 (1) , 23
Open AccessFailure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD
Background: The lectin-like oxidized LDL receptor LOX-1 (encoded by OLR1) is believed to play a key role in atherogenesis and some reports suggest an association of OLR1 polymorphisms with myocardial infarction (MI). We tested whether single nucleotide polymorphisms (SNPs) in OLR1 are associated with clinically significant CAD in the Atherosclerotic Disease, VAscular FuNction, & Geneti C Epidemiology (ADVANCE) study. Methods: ADVANCE is a population-based case-control study of subjects receiving care within Kaiser Permanente of Northern California including a subset of participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study. We first resequenced the promoter, exonic, and splice site regions of OLR1 and then genotyped four single nucleotide polymorphisms (SNPs), including a non-synonymous SNP (rs11053646, Lys167Asn) as well as an intronic SNP (rs3736232) previously associated with CAD. Results: In 1,809 cases with clinical CAD and 1,734 controls, the minor allele of the coding SNP was nominally associated with a lower odds ratio (OR) of CAD across all ethnic groups studied (minimally adjusted OR 0.8, P = 0.007; fully adjusted OR 0.8, P = 0.01). The intronic SNP was nominally associated with an increased risk of CAD (minimally adjusted OR 1.12, p = 0.03; fully adjusted OR 1.13, P = 0.03). However, these associations were not replicated in over 13,200 individuals (including 1,470 cases) in the Atherosclerosis Risk in Communities (ARIC) study. Conclusion: Our results do not support the presence of an association between selected common SNPs in OLR1 and the risk of clinical CAD.
- 1 February 2008
- Published by Elsevier in Annals of Epidemiology
- Vol. 18 (2) , 101-107
Relationship of Alcohol Consumption and Type of Alcoholic Beverage Consumed With Plasma Lipid Levels: Differences Between Whites and African Americans of the ARIC Study
- 1 February 2008
- Published by Elsevier in Annals of Epidemiology
- Vol. 18 (2) , 101-107
Relationship of Alcohol Consumption and Type of Alcoholic Beverage Consumed With Plasma Lipid Levels: Differences Between Whites and African Americans of the ARIC Study
- 1 November 2007
- Published by Elsevier in Atherosclerosis
- Vol. 195 (1) , e76-e82
Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) study
- 1 November 2007
- Published by Elsevier in Atherosclerosis
- Vol. 195 (1) , e76-e82
Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) study
- 1 July 2007
- Published by Alcohol Research Documentation, Inc. in Journal of Studies on Alcohol and Drugs
- Vol. 68 (4) , 485-492
Interaction Effects of High-Density Lipoprotein Metabolism Gene Variation and Alcohol Consumption on Coronary Heart Disease Risk: The Atherosclerosis Risk in Communities Study
Objective: Light to moderate alcohol consumption has been widely established to be protective against coronary heart disease (CHD), whereas heavy alcohol consumption has been shown to have a potent...
- 1 July 2007
- Published by Alcohol Research Documentation, Inc. in Journal of Studies on Alcohol and Drugs
- Vol. 68 (4) , 485-492
Interaction Effects of High-Density Lipoprotein Metabolism Gene Variation and Alcohol Consumption on Coronary Heart Disease Risk: The Atherosclerosis Risk in Communities Study
Objective: Light to moderate alcohol consumption has been widely established to be protective against coronary heart disease (CHD), whereas heavy alcohol consumption has been shown to have a potent...